Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in painful diabetic peripheral neuropathy extension study
NCT00141401Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 1999
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in diabetic peripheral neuropathy (DPN), sponsored by Pfizer. Primary endpoints: Safety and Efficacy. Started Sep 1999; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00141401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141401.